WAM
WST icon

Weiss Asset Management’s West Pharmaceutical WST Stock Holding History

Weiss Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,924
Closed -$1.99M – 851
2026
Q1 		$1.99M Buy
+7,924
New +$1.97M 0.03% 266
2025
Q3 		– Sell
-32,175
Closed -$7.04M – 802
2025
Q2 		$7.04M Buy
+32,175
New +$6.88M 0.08% 138
2024
Q4 		– Sell
-953
Closed -$286K – 900
2024
Q3 		$286K Buy
+953
New +$292K 0.01% 539
2023
Q2 		– Sell
-2,200
Closed -$762K – 320
2023
Q1 		$762K Buy
+2,200
New +$643K 0.05% 188
2021
Q3 		– Sell
-2,762
Closed -$992K – 618
2021
Q2 		$992K Buy
+2,762
New +$913K 0.02% 365

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Weiss Asset Management's WST Position: Q2 2026 in Review

Weiss Asset Management sold out of West Pharmaceutical (WST) in Q2 2026, closing a stake of 7,924 shares — an estimated $1.99M sold.

Weiss Asset Management first reported a position in WST in Q2 2021 and held it in 5 quarters. The position peaked at $7.04M in Q2 2025. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Weiss Asset Management reported no remaining West Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Weiss Asset Management sold 7,924 West Pharmaceutical shares in Q2 2026, an estimated $1.99M.
  • Weiss Asset Management first reported a position in West Pharmaceutical in Q2 2021 and held it in 5 quarters.
  • Weiss Asset Management's West Pharmaceutical position peaked at $7.04M in Q2 2025.
  • 833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.